NOT KNOWN FACTUAL STATEMENTS ABOUT SR9009

Cure with SR18662 drastically reduces advancement and proliferation of CRC cells. SR18662 displays improved efficacy in cutting down viability of various CRC mobile lines. Stream cytometry Evaluation subsequent SR18662 cure displays an increase in cells captured in both S or G2/M phases from the mobile cycle and a substantial boost in the volume of